Recombinant Human GIP Protein

重组人GIP蛋白 | 重组人抑胃肽蛋白

Gastric Inhibitory Peptide | Gastric inhibitory polypeptide | Gastric inhibitory polypeptide precursor | GIP | GIP_HUMAN | Glucose dependent insulinotropic polypeptide | Glucose-dependent insulinotropic polypeptide | Incretin hormone

rp188399-10μg

10μg

无载体

≥90%(SDS-PAGE)

Glucose-dependent insulinotropic polypeptide (GIP) is an incretin that plays an important role in fat accumulation. GIP is involved in fat accumulation and insulin resistance with aging. Glucose-dependent insulinotropic polypeptide (GIP) is an intestinal hormone with a broad range of physiological actions. Elevated concentrations of the incretin hormone GIP are found in patients with atherosclerotic cardiovascular disease, while GIP treatment attenuates atherosclerotic plaque inflammation in mice and abrogates inflammatory macrophage activation in vitro. That GIP as a counterregulatory vasoprotective peptide, which might open new therapeutic avenues for the treatment of patients with high cardiovascular risk.

Testing in progress

重组表达

15.9 kDa

N-His

16.6 kDa, under reducing conditions; 16.6 kDa, under non-reducing conditions.

E. coli Accession #: P09681 | E. coli

<1.0 EU/μg

人(Human)

22-153 aa

MHHHHHHEKKEGHFSALPSLPVGSHAKVSSPQPRGPRYAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQREARALELASQANRKEEEAVEPQSSPAKNPSDEDLLRDLLIQELLACLLDQTNLCRLRSR

No

Yes